WebApr 10, 2024 · FE-SYHA1402: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ZhongQi Pharmaceutical Technology is conducting a multiple doses study to evaluate the safety, tolerability, pharmacokinetics (including food effect) of SYHA1402 in healthy subjects. This study consists of two parts: The objective of the food effect study (Part 1) … WebApr 26, 2024 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. Provider of Information About this Clinical Study Sponsor; Overall Official(s) Lingying Wu, Medical PhD, Principal Investigator, Chinese Academy of Medical Sciences and Peking Union Medical College; Overall Contact(s) Beibei Zhai, 0086-021-60673937, [email protected]
CSPC WEISHENG PHARMACEUTICAL (SHIJIAZHUANG) CO., LTD.
Web@@ 山东红梅园艺科技有限公司是一家集研发、生产、技术培训、应用推广和国际交流为一体的专业产业集团,下辖投资控股山东都市农业科技有限公司、宁夏乐义国际农业发展有限公司、山东省现代农业技工学校等专业公司或机构,并在德国设有分支机构,在山东、宁夏、北京、云南等地建有多处高标准 ... WebFeb 25, 2024 · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. ClinicalTrials.gov Identifier: NCT03852823 Other Study ID Numbers: SG001202401 : First Posted: … can muscle fascia be repaired
CSPC ZhongQi Pharmaceutical Technology Co Ltd - PatientWing
WebShijiazhuang Pharma Group (CSPC) Report issue. Shijiazhuang Pharma Group (CSPC) Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4. Founded: Hong Kong China (1992) Status: No NME R&D (1992) WebMay 9, 2024 · May 09, 2024 13:00 ET Source: DelveInsight Business Research LLP. New York, USA, May 09, 2024 (GLOBE NEWSWIRE) -- Allergic Rhinitis Pipeline To Progress With Novel and Emerging Drugs, Analyzes ... WebCSPC has a leading R&D team of more than 2,000 people in China with over 200 talents with doctorate or overseas experience. Research and development bases are located in Shijiazhuang, Shanghai, Beijing and the United States, focusing on the discovery, research and development of small molecule target drugs, nano-drugs, monoclonal antibody … fixing a drain in a bathtub